Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison

Title:Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison

Volume: 20 Issue: 6

Author(s): Behnam Farhoudi, SeyedAhmad SeyedAlinaghi*, Bahar Ataeinia, Mostafa Hosseini, Sirous Jafari, Ramin Alasvand, Mehrzad Tashakoriyan and Minoo Mohraz

Affiliation:

• Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran,Iran

Keywords: HIV/AIDS, prison, guideline, indicators, HIV testing, antiretroviral therapy.

Abstract:

Objectives: A new national clinical guideline for the management of tuberculosis and HIV in Iranian prisons was released in 2011. The aim of this study was to compare HIV indicators in the case and control prisons after implementation of the new guideline.

Methods: This report examines outcomes observed during the pilot phase of its implementation at a case prison from October 2013 to June 2014 compared to a control prison that had not yet implemented the guideline. The case prison included incarcerated individuals in the Great Tehran Prison. A prison in Alborz province was considered as a control group. Pearson’s Chi-squared, two-sample t-test, paired t-test and Kruskal-Wallis were used for the analysis.

Results: The intervention significantly increased the total number of inmates tested for HIV and of diagnoses of HIV-positive inmates in the case prison compared to the control prison (P<0.001). Moreover, coverage of antiretroviral therapy was higher in the case prison compared to the control prison (P=0.015).

Conclusion: We recommend the implementation of this guideline in all Iranian prisons.

Cite this article as:

Farhoudi Behnam, SeyedAlinaghi SeyedAhmad*, Ataeinia Bahar, Hosseini Mostafa, Jafari Sirous, Alasvand Ramin, Tashakoriyan Mehrzad and Mohraz Minoo, Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison, Infectious Disorders - Drug Targets 2020; 20 (6) . https://dx.doi.org/10.2174/1871526519666191015151639